Optimization of live oral Salmonella-HIV-1 vaccine vectors for the induction of HIV-specific mucosal and systemic immune responses

Journal of Biotechnology

Volumn 44, Issue 1-3, 1996, Pages 203-207

  Hone, David M ^a   Wu, Shaoguang ^a   Powell, Robert J ^a   Pascual, David W ^b   Van Cott, John ^b   McGhee, Jerry ^b   Fouts, Timothy R ^c   Tuskan, Robert G ^a   Lewis, George K ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c AARON DIAMOND AIDS RESEARCH CENTER   (United States)

Author keywords

Gp120; HIV 1; Mucosal immunity; Salmonella; Vaccine vector

Indexed keywords

ANTIGENS; IMMUNIZATION; LIVING SYSTEMS STUDIES; VIRUSES;

CELL MEDIATED IMMUNITY; HUMAN IMMUNODEFICIENCY VIRUS; MUCOSAL IMMUNE RESPONSE; SALMONELLA; SYSTEMIC IMMUNE RESPONSE; VACCINE VECTORS;

VACCINES;

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIVE VACCINE; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; EXPRESSION VECTOR; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNITY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SALMONELLA; VACCINATION;

EID: 0030047688     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-1656(95)00151-4     Document Type: Conference Paper

References (25)

1. Abacioglu, Y.H., Fouts, T.R., Laman, J., Claassen, E., Pincus, S.H., Moore, J.P., Roby, C.A., Kamin-Lewis, R.M. and Lewis, O.K. (1994) Epitope mapping and topology of baculovirus expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies. AIDS Res. Human Retroviruses 10, 371-381.
2. + cytotoxic T cells. J. Exp. Med. 172, 1083.
3. Beagley, K.W., Eldridge, J.H., Kiyono, H., Everson, M.P., Koopman, W.J., Honjo, T. and McGhee, J.R. (1988) Recombinant murine IL-5 induces high rate sIgA synthesis in cycling IgA-positive Peyer's patch B cells. J. Immunol. 141:2035-2040.
4. Berman, P.W., Gregory, T.J., Riddle, L., Nakamura, G.R., Champe, M.A., Porter, J.P., Wurm, F.M., Hersenberg, R.D., Cobb, E.K. and Eichberg, J.W. (1991) Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature 345, 622-625.
5. Brown, A. and Hormaeche, C. (1989) The antibody response to Salmonellae in mice and humans studied by immunoblots and ELISA. Microb. Pathog. 6, 445-454.
6. Derman, A.I., Prinz, W.A., Belin, D. and Beckwith, J. (1993) Mutations that allow disulphide bond formation in the cytoplasm of Escherichia coli. Science 262, 1744-1747.
7. Fouts, T.R., Lewis, G.K. and Hone, D.M. (1993) Construction and characterization of a Salmonella-based Human Immundefficiency Virus type 1 vector vaccine. In: Vaccines 93. Modern Approaches to New Vaccines Including Prevention of AIDS. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. pp. 95-100.
8. Fouts, T.R., Lewis, G.K. and Hone, D.M. (1995a) Construction and characterization of a Salmonella-based human immundeficiency virus type 1 vector vaccine. Vaccine, in press.
9. Fouts, T.R., Tuskan, R.G., Chanda, S., Hone, D.M. and Lewis, G.K. (1995b) Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-I gp120. Vaccine, in press.
10. Gao, X.-M., Tite, J.P., Lipscombe, M., Rowland-Jones, S., Ferguson, D.J.P. and McMichael, A.J. (1992) Recombinant Salmonella typhimurium strain that invade nonphagocytic cells are resistant to recognition by antigen-specific cytotoxic T lymphocytes. Infect. Immun. 60, 3780-3782.
11. Goldberg, A.L. and Golf, S.A. (1986) The selective degradation of abnormal proteins in bacteria. In: Maximizing Gene Expression. Butterworth Publishers, Stoneham, MA. pp. 287-314.
12. Hone, D.M., Tackett, C.O., Harris, A., Kay, B., Losonski, J. and Levine, M.M. (1992) Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine. J. Clin. Invest. 90, 412-418.
13. Hornquist, E., Enerbalc, L., Chen, X.J. and Lycke, N. (1993) A novel large granular lymphocyte-like cell isolated from IL-2 supplemented murine intestinal lamina propria lymphocyte cultures with potent inhibitory action on lymphocyte proliferation. Cell. Immunol. 148, 71-90.
14. King, J. and Haase-Pettingell, C. (1988) Aggregate formation from thermolabile intermediates in the maturation of the thermostable P22 tailspike. Biochem. Soc. Trans. 16, 105-108.
15. Koup, R.A. and Ho, D.D. (1994) Shutting down HIV. Nature 370, 416.
16. + cell anti-HIV activity correlates with the clinical state of the infected individual. J. Clin. Invest. 87, 1462-1466.
17. Marston, A.O. (1986) The purification of eukaryotic polypeptides synthesized in Escherichia coli. Biochem. J. 240, 1-12.
18. Nikaido, H. and Vaara, M. (1984) Outer membrane. In: Neidhardt, F.C. (Ed.), Escherichia coli and Salmonella typhimurium. Cellular and Molecular biology, Vol. 1. American Society of Microbiologists, Washington DC. pp. 7-13.
19. Pfeifer, J.D., Wick, M.J., Roberts, R.L., Findlay, K., Normark, S.J. and Harding, C.V. (1993) Phagocytic processing of bacterial antigens for class 1 MHC presentation to T cells. Nature 361, 359-361.
20. Sambrook, J., Fritsch, E.F. and Maniatis, T. (Eds.) (1989) Molecular Cloning. A Laboratory Manual. 2nd edn. Cold Spring Harbor Press, Cold Spring Harbor, NY.
21. Schein, C.H. (1989) Production of soluble recombinant proteins in bacteria. Bio/technology 7, 1141-1149.
22. Turner, S.J., Carbone, F.R. and Strugnell, R.A. (1993) Salmonella typhimurium ΔaroA ΔaroD mutants expressing a foreign recombinant protein induce specific major histocompatibility complex class I-restricted cytotoxic T lymphocytes in mice. Infect. Immun. 61, 5374-5380.
23. Udhayakumar, V. and Muthukkaruppan, V.R. (1987) An outer membrane protein (Porin) as an eliciting antigen for delayed-type hypersensitivity in murine salmonellosis. Infect. Immun. 55, 822.
24. Wu, S., Pascual, D.W., Powell, R.J., Van Cott, J., McGhee, J., Lewis, G.K. and Hone, D.M. (1995) Oral immunization of mice with a live attenuated Salmonella vector expressing recombinant gp120 of HIV-1 on the surface of the vector induces humoral response against gp 120, In press.
25. -) vaccine expressing a major Leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against Leishmaniasis. J. Immunol. 145, 2281-2285.